Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ADENO-ASSOCIATED VIRUS VECTORS AND METHODS OF THEIR USE FOR REDUCING THE RISK OF, TREATING, AND PREVENTING METASTASIS
Document Type and Number:
WIPO Patent Application WO/2024/026319
Kind Code:
A3
Abstract:
The disclosure provides recombinant adeno-associated viral (rAAV) vectors expressing a bispecific fusion protein that binds GD2 and CD3, and methods of using the same for reducing the risk of, preventing, or treating metastasis. The disclosure also provides rAAV vectors for expressing the bispecific fusion protein.

Inventors:
CRIPE TIMOTHY P (US)
GYULAY LANDON (US)
KASPAR BRIAN (US)
KASPAR ALLAN (US)
VARMA SAMIT (US)
GARDINIER SCOTT JACOB (US)
Application Number:
PCT/US2023/070964
Publication Date:
April 18, 2024
Filing Date:
July 25, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
VIRONEXIS BIOTHERAPEUTICS INC (US)
International Classes:
A61K39/395; C07K16/28; C12N15/113; C12N15/864
Domestic Patent References:
WO2021242848A12021-12-02
WO2021154839A12021-08-05
WO2021048724A12021-03-18
Foreign References:
US20160032009A12016-02-04
US20160168211A12016-06-16
Attorney, Agent or Firm:
DUSABAN GONZALES, Stephanie et al. (US)
Download PDF: